SCHEMBL7368979

SCHEMBL7368979

N#Cc1cc(C(=O)CBr)cc(O)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.47
PTPN1 P18031 4/20 0.40
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
TP53 P04637 1/20 0.35
CA3 P07451 1/20 0.35
SELL P14151 1/20 0.35
HPGD P15428 1/20 0.35
SELP P16109 1/20 0.35
FUT4 P22083 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
DPP4 P27487 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22242886 0.85 GSK3B (0.46) GSK3BPTPN1CYP2C9SLC22A12
SCHEMBL18629884 0.83 GSK3B (0.45) GSK3BPTPN1ALDH1A1MAPTCYP2C9
SCHEMBL8542530 0.78 CA12 (0.61) KDM4EALDH1A1LMNAMAPTTDP1
SCHEMBL7369949 0.77 CA5A (0.43) KDM4EALDH1A1LMNAMAPTTDP1
SCHEMBL8881196 0.76 GSK3B (0.44) GSK3BPTPN1
SCHEMBL8731830 0.75 KDM4E (0.42) KDM4EALDH1A1LMNAMAPTTDP1
SCHEMBL29896949 0.75 GSK3B (0.54) GSK3BPTPN1CNR2
SCHEMBL14720129 0.75 GSK3B (0.54) GSK3BPTPN1CNR2
SCHEMBL10493758 0.73 GSK3B (0.41) GSK3BPTPN1KDM4EALDH1A1LMNA
SCHEMBL23317589 0.72 GSK3B (0.44) GSK3BPTPN1ALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed